Cancer May Lend Key Clues for Cardiovascular Risk Analysis

Utilization of metabolomics to identify serum biomarkers for hepatocellular carcinoma in patients with liver cirrhosis

(2012) Habtom W. Ressom et al.   ANALYTICA CHIMICA ACTA

Coronary risk assessment among intermediate risk patients using a clinical and biomarker based algorithm developed and validated in two population cohorts

(2012) D.S. Cross et al.   CURRENT MEDICAL RESEARCH AND OPINION

Cardioprotection Against Ischemia/Reperfusion Injury and Chromogranin ADerived Peptides

(2012) C. Penna et al.   CURRENT MEDICINAL CHEMISTRY

A multi-biomarker risk score improves prediction of long-term mortality in patients with advanced heart failure

(2012) Bernhard Richter et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Lactoferrin-Endothelin-1 Axis Contributes to the Development and Invasiveness of Triple-Negative Breast Cancer Phenotypes

(2011) N.-H. Ha et al.   CANCER RESEARCH

A Novel Prosurvival Model for Cancer Under Environmental Challenge: The “Heart-Felt” Message for Therapeutic Intervention

(2011) John A. Loudon   ONCOLOGY RESEARCH

High-density lipoprotein determines adult mouse cardiomyocyte fate after hypoxia-reoxygenation through lipoprotein-associated sphingosine 1-phosphate

(2010) Rong Tao et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Gene expression profile of rat left ventricles reveals persisting changes following chronic mild exercise protocol: implications for cardioprotection

(2009) Betti Giusti et al.   BMC GENOMICS

Tissue Kallikrein Elicits Cardioprotection by Direct Kinin B2 Receptor Activation Independent of Kinin Formation

(2008) Julie Chao et al.   HYPERTENSION

Clinical correlations and prognostic relevance of HGF, VEGF AND FGF expression in Brazilian patients with non-Hodgkin lymphoma

(2008) Leina Etto et al.   LEUKEMIA & LYMPHOMA